State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2016, Issue -, Pages 1-19
Publisher
Hindawi Limited
Online
2016-10-25
DOI
10.1155/2016/1412840
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
- (2016) Jean-Michel Pawlotsky GASTROENTEROLOGY
- Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)
- (2016) Eric Lawitz et al. HEPATOLOGY
- Hepatitis C genotype 3 disease
- (2016) Sarah Kattakuzhy et al. Hepatology International
- Evaluation of a commercial real-time PCR kit for the detection of the Q80K polymorphism in plasma from HCV genotype 1a infected patients
- (2016) Ilaria Vicenti et al. JOURNAL OF CLINICAL VIROLOGY
- The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
- (2016) Christoph Sarrazin JOURNAL OF HEPATOLOGY
- Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals
- (2016) Nicola Coppola et al. JOURNAL OF MEDICAL VIROLOGY
- Universal screening for chronic hepatitis C virus
- (2016) Mitchell L. Shiffman LIVER INTERNATIONAL
- 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV
- (2016) Julie Bottero et al. LIVER INTERNATIONAL
- Status of hepatitis C virus vaccination: Recent update
- (2016) Kouka Saadeldin Abdelwahab WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
- (2016) Miguel Jiménez-Pérez et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Improving Access to Hepatitis C Care for Urban, Underserved Patients Using a Primary Care-Based Hepatitis C Clinic
- (2016) Lesley Miller et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Simeprevir and sofosbuvir for treatment of hepatitis C infection
- (2015) Shelby Chopp et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir
- (2015) Rong Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region
- (2015) Christoph Sarrazin et al. ANTIVIRAL RESEARCH
- Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naïve patients with chronic hepatitis: single-centre experience
- (2015) Tina Ruggiero et al. ARCHIVES OF VIROLOGY
- Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse
- (2015) Samuel B. Ho et al. Clinical Gastroenterology and Hepatology
- Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy
- (2015) L. Boglione et al. CLINICAL MICROBIOLOGY AND INFECTION
- Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in hepatitis C virus genotype 1a strains in the UK
- (2015) A. Beloukas et al. CLINICAL MICROBIOLOGY AND INFECTION
- Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- Hepatitis C Virus
- (2015) Georg Dultz et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Epidemiology of Hepatitis C Virus
- (2015) Norah J. Shire et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Molecular principles behind Boceprevir resistance due to mutations in hepatitis C NS3/4A protease
- (2015) Neha Nagpal et al. GENE
- Hepatitis C virus drug resistance-associated substitutions: State of the art summary
- (2015) Erik Lontok et al. HEPATOLOGY
- Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
- (2015) HEPATOLOGY
- Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department
- (2015) James W. Galbraith et al. HEPATOLOGY
- Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy
- (2015) Jun Itakura et al. HEPATOLOGY RESEARCH
- Worldwide distribution of the NS3 gene 80K polymorphism among circulating hepatitis C genotype 1 viruses: implication for simeprevir usage
- (2015) L. L. Vidal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin
- (2015) Sylvie Larrat et al. JOURNAL OF CLINICAL MICROBIOLOGY
- HCV NS3 quasispecies in liver and plasma and dynamics of telaprevir-resistant variants in breakthrough patients assessed by UDPS: A case study
- (2015) Barbara Bartolini et al. JOURNAL OF CLINICAL VIROLOGY
- Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice
- (2015) Yugo Kai et al. JOURNAL OF GASTROENTEROLOGY
- Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program
- (2015) Stacey B. Trooskin et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Management of direct-acting antiviral agent failures
- (2015) Maria Buti et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4
- (2015) Christophe Moreno et al. JOURNAL OF HEPATOLOGY
- O059 : Long-term persistence of HCV NS5A variants after treatment with NS5A inhibitor ledipasvir
- (2015) H. Dvory-Sobol et al. JOURNAL OF HEPATOLOGY
- O057 : Long-term follow-up of treatment-emergent resistance-associated variants in NS3, NS5A and NS5B with paritaprevir/r-, ombitasvir- and dasabuvir-based regimens
- (2015) P. Krishnan et al. JOURNAL OF HEPATOLOGY
- Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies
- (2015) Oliver Lenz et al. JOURNAL OF HEPATOLOGY
- Implementing hospital-based baby boomer hepatitis c virus screening and linkage to care: Strategies, results, and costs
- (2015) Barbara J. Turner et al. Journal of Hospital Medicine
- Diversity of 1,213 hepatitis C virus NS3 protease sequences from a clinical virology laboratory database in Marseille university hospitals, southeastern France
- (2015) Hind Hajji et al. JOURNAL OF MEDICAL VIROLOGY
- Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients
- (2015) Julia Dietz et al. PLoS One
- Progress in the development of vaccines for hepatitis C virus infection
- (2015) Faezeh Ghasemi WORLD JOURNAL OF GASTROENTEROLOGY
- Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance
- (2015) Lize Cuypers et al. Viruses-Basel
- Resistance to direct-acting antiviral agents
- (2015) Valeria Cento et al. Current Opinion in HIV and AIDS
- Successes and Challenges on the Road to Cure Hepatitis C
- (2015) Stacy M. Horner et al. PLoS Pathogens
- Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden
- (2015) Ida Lindström et al. Infectious Diseases
- Diagnostic Accuracy of Point-of-Care Tests for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis
- (2015) Mehnaaz Sultan Khuroo et al. PLoS One
- Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity
- (2014) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors
- (2014) V. C. Di Maio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral therapy of hepatitis C in 2014: Do we need resistance testing?
- (2014) Maximilian David Schneider et al. ANTIVIRAL RESEARCH
- Virologic escape in HCV genotype 1-infected patients receiving daclatasvir plus ribavirin and peginterferon alfa-2a or alfa-2b
- (2014) Fiona McPhee et al. ANTIVIRAL THERAPY
- Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe
- (2014) Achim Kautz et al. BMC INFECTIOUS DISEASES
- Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials
- (2014) Evguenia S. Svarovskaia et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis C Core Antigen Testing: A Reliable, Quick, and Potentially Cost-effective Alternative to Hepatitis C Polymerase Chain Reaction in Diagnosing Acute Hepatitis C Virus Infection
- (2014) Fiona V. Cresswell et al. CLINICAL INFECTIOUS DISEASES
- Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
- (2014) Xavier Forns et al. GASTROENTEROLOGY
- Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations
- (2014) Leticia de Paula Scalioni et al. JOURNAL OF CLINICAL VIROLOGY
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Influence of CD8 T cell priming in liver and gut on the enterohepatic circulation
- (2014) Ira Eickmeier et al. JOURNAL OF HEPATOLOGY
- P1230 LACK OF IMPACT OF BASELINE RESISTANCE-ASSOCIATED VARIANTS (RAVS) ON TREATMENT OUTCOME IN THE AVIATOR STUDY WITH ABT-450/R, ABT-333 AND ABT-267, +/– RIBAVIRIN
- (2014) P. Krishnan et al. JOURNAL OF HEPATOLOGY
- Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial
- (2014) W. Halota et al. JOURNAL OF VIRAL HEPATITIS
- Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
- (2014) Ira M Jacobson et al. LANCET
- Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Michael Manns et al. LANCET
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis C Worldwide and in Brazil: Silent Epidemic—Data on Disease including Incidence, Transmission, Prevention, and Treatment
- (2014) Iara Fabricia Kretzer et al. TheScientificWorldJOURNAL
- Hepatitis C virus NS5A inhibitors and drug resistance mutations
- (2014) Shingo Nakamoto WORLD JOURNAL OF GASTROENTEROLOGY
- Diagnostic tests for hepatitis C: Recent trends in electrochemical immunosensor and genosensor analysis
- (2014) Carolina V Uliana WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
- (2014) Filippo Ansaldi WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin
- (2014) John A. Howe et al. Open Forum Infectious Diseases
- Birth Cohort Screening for Chronic Hepatitis During Colonoscopy Appointments
- (2013) Dawn M Sears et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Indications for Testing Among Reported Cases of HCV Infection From Enhanced Hepatitis Surveillance Sites in the United States, 2004–2010
- (2013) Reena Mahajan et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study
- (2013) R. T. Chung et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Hepatitis C Virus Testing of Persons Born During 1945–1965: Recommendations From the Centers for Disease Control and Prevention
- (2013) Bryce D. Smith et al. ANNALS OF INTERNAL MEDICINE
- Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C
- (2013) Sushmita Shivkumar et al. ANNALS OF INTERNAL MEDICINE
- Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a
- (2013) Navaneethan Palanisamy et al. ANTIVIRAL RESEARCH
- Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
- (2013) Susan JM Hahné et al. BMC INFECTIOUS DISEASES
- Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
- (2013) Michela Flego et al. BMC Medicine
- Incident Hepatitis C Virus Infection in Men Who Have Sex With Men: A Prospective Cohort Analysis, 1984-2011
- (2013) M. D. Witt et al. CLINICAL INFECTIOUS DISEASES
- Executive Summary: Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
- (2013) J. A. Aberg et al. CLINICAL INFECTIOUS DISEASES
- Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit All
- (2013) Philip Bruggmann et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes of Hepatitis C Treated with Pegylated Interferon and Ribavirin via Telemedicine Consultation in Northern California
- (2013) Lorenzo Rossaro et al. DIGESTIVE DISEASES AND SCIENCES
- A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care
- (2013) Christopher E. McGowan et al. HEPATOLOGY
- The effects of female sex, viral genotype, andIL28Bgenotype on spontaneous clearance of acute hepatitis C virus infection
- (2013) Jason Grebely et al. HEPATOLOGY
- Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir
- (2013) Fiona McPhee et al. HEPATOLOGY
- Hepatitis and liver disease knowledge and preventive practices among health workers in Mexico: a cross-sectional study
- (2013) Noreen Islam et al. International Journal of Public Health
- Natural prevalence of NS5A polymorphisms in subjects infected with hepatitis C virus genotype 3 and their effects on the antiviral activity of NS5A inhibitors
- (2013) Dennis Hernandez et al. JOURNAL OF CLINICAL VIROLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- In Vivo Emergence of a Novel Mutant L159F/L320F in the NS5B Polymerase Confers Low-Level Resistance to the HCV Polymerase Inhibitors Mericitabine and Sofosbuvir
- (2013) Xiao Tong et al. JOURNAL OF INFECTIOUS DISEASES
- Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response
- (2013) Samali Lubega et al. LIVER INTERNATIONAL
- Current progress in development of hepatitis C virus vaccines
- (2013) T Jake Liang NATURE MEDICINE
- Hepatitis C in the United States
- (2013) Scott D. Holmberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
- (2013) David Gardiner et al. PLoS One
- Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients
- (2013) Stefania Paolucci et al. Virology Journal
- Hepatitis C virus infection and related liver disease: the quest for the best animal model
- (2013) Laurent Mailly et al. Frontiers in Microbiology
- Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents
- (2013) Jinhong Chang et al. Emerging Microbes & Infections
- Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir
- (2012) Fiona McPhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor
- (2012) Zulema Plaza et al. ANTIVIRAL THERAPY
- Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study
- (2012) Anne C. Moorman et al. CLINICAL INFECTIOUS DISEASES
- Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men
- (2012) Benjamin P. Linas et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis C Virus Infections in the Swiss HIV Cohort Study: A Rapidly Evolving Epidemic
- (2012) Gilles Wandeler et al. CLINICAL INFECTIOUS DISEASES
- Laboratory Diagnostics for Hepatitis C Virus Infection
- (2012) Saleem Kamili et al. CLINICAL INFECTIOUS DISEASES
- Electronic Messages Increase Hepatitis B Screening in At-Risk Asian American Patients: A Randomized, Controlled Trial
- (2012) Leeyen Hsu et al. DIGESTIVE DISEASES AND SCIENCES
- Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease
- (2012) Jens Bukh GASTROENTEROLOGY
- Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b
- (2012) Fumitaka Suzuki et al. JOURNAL OF CLINICAL VIROLOGY
- A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C
- (2012) Eric J. Lawitz et al. JOURNAL OF HEPATOLOGY
- Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir
- (2012) Yoshiyasu Karino et al. JOURNAL OF HEPATOLOGY
- Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
- (2012) Yoshiyuki Suzuki et al. JOURNAL OF HEPATOLOGY
- NASPGHAN Practice Guidelines
- (2012) Cara L. Mack et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Persistent hepatitis C virus (HCV) infection impairs HCV-specific cytotoxic T cell reactivity through Mcl-1/Bim imbalance due to CD127 down-regulation
- (2012) J. R. Larrubia et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment
- (2012) Doug J. Bartels et al. JOURNAL OF VIROLOGY
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors
- (2012) Valeria Cento et al. PLoS One
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
- (2012) E. Barnes et al. Science Translational Medicine
- Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection
- (2012) Brian Clark et al. Patient Preference and Adherence
- In VitroActivity of BMS-790052 on Hepatitis C Virus Genotype 4 NS5A
- (2011) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1–5
- (2011) Sophie Vallet et al. ANTIVIRAL THERAPY
- Incidence and Transmission Patterns of Acute Hepatitis C in the United States, 1982-2006
- (2011) Ian T. Williams et al. ARCHIVES OF INTERNAL MEDICINE
- A Poxvirus Vaccine Is Safe, Induces T-Cell Responses, and Decreases Viral Load in Patients With Chronic Hepatitis C
- (2011) François Habersetzer et al. GASTROENTEROLOGY
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008
- (2011) Maxine M. Denniston et al. HEPATOLOGY
- Hepatitis C virus core antigen: Analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay
- (2011) Maria Cristina Medici et al. JOURNAL OF CLINICAL VIROLOGY
- Perspective: Test and treat this silent killer
- (2011) Brian R. Edlin NATURE
- Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
- (2011) Sanjeev Arora et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System
- (2010) R. A. Fridell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers
- (2010) Debbie Drane et al. Human vaccines & immunotherapeutics
- Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia
- (2010) J. Grebely et al. JOURNAL OF VIRAL HEPATITIS
- Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity
- (2010) F. Alborino et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine
- (2010) Christa Firbas et al. VACCINE
- Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
- (2010) Sharon E. Frey et al. VACCINE
- Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
- (2009) Margaret Hellard et al. CLINICAL INFECTIOUS DISEASES
- Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C
- (2009) Heiner Wedemeyer et al. VACCINE
- Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41
- (2008) Christoph S. Klade et al. GASTROENTEROLOGY
- Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy
- (2008) Silvana Gaudieri et al. HEPATOLOGY
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
- Rates of evolutionary change in viruses: patterns and determinants
- (2008) Siobain Duffy et al. NATURE REVIEWS GENETICS
- Cost-Effectiveness of the National Screening Program for Hepatitis C Virus in the General Population and the High-Risk Groups
- (2008) Junichiro Nakamura et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now